SpaceX Shares Are Sliding: A Contrarian Buying Opportunity Worth Considering

SpaceX shares fell from an early-June IPO peak of $225.64 to about $162, but remain above the $135 IPO price. The article highlights Starlink’s scale—~60% of $18.7B revenue and $4.4B operating income in 2025, plus 10.3M users in Q1’26—alongside major AI compute commitments (Alphabet at ~$920M/month and Anthropic for Colossus 1 capacity), and a FCC nod for 7,500 more Gen2 satellites (total authorized 15,000). Key risks include a premium valuation (~81x trailing sales) and Starship execution warnings from NASA’s inspector general, with additional near-term support potentially coming from Nasdaq-100 index inclusion (estimated ~$4.3B of buying) despite short interest rising to 196M shares (~31% of float).

Analysis

Near term, this is more a plumbing/positioning story than a pure fundamentals story. The stock has a mechanical bid from index demand, while elevated short interest means the first leg higher can be driven by forced buying rather than incremental conviction; that makes the tape fragile once the rebalance window passes. In other words, the market may be paying up for scarcity of float, not yet for a clean cash-flow compounding story.

The real fundamental question is whether the market should capitalize the company like a hardware-growth platform or like a recurring network business. If the connectivity franchise keeps throwing off cash, it can subsidize the rest of the stack; if not, the high-multiple valuation becomes hostage to execution on projects that are capital intensive and timing-sensitive. For NVDA, the relevant effect is not company-specific upside from one customer, but confirmation that AI demand remains supply-constrained across nontraditional buyers, which supports utilization and pricing power.

Contrarian risk: consensus may be overestimating how durable index-driven demand is and underestimating how quickly the narrative can flip after the event. The key falsifier over 1-3 months is a failure to convert post-IPO enthusiasm into sustained trading above the opening range; over 6-18 months, the falsifier is any slip in launch cadence, satellite economics, or monetization quality that forces the market to reassess the premium. If that happens, the stock likely de-rates faster than peers because the valuation leaves little room for execution noise.

Key Decisions for Investors

• Avoid chasing SPCX into the index-addition window; wait for the mechanical flow to clear, then look to short any post-rebalance pop over a 1-3 month horizon if borrow remains available. Risk: persistent squeeze pressure and additional lockup/float constraints; invalidate on a sustained hold above the post-inclusion high.
• Prefer long NVDA vs. SPCX as a cleaner way to express AI capex intensity. NVDA monetizes demand regardless of which platform wins, while SPCX still has to prove it can turn ambitious expansion into durable free cash flow; target 3-6 months, with the pair leaning in NVDA's favor if AI capex remains tight.
• Use SPCX only as a tactical event-driven long if the stock can digest the index buy and hold gains above the IPO area after the rebalance. If it cannot hold that level, treat the move as flow-driven and fade it; if it does, reassess for a longer-duration trend trade.
• Set a watch item on execution milestones rather than headlines: any delay in launch cadence, satellite deployment, or monetization should be treated as the real de-rating catalyst, not broader market volatility.